Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Neurology. Genetics|June 22, 2023
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in AfricansNomakhosazana R Monnakgotla, Amokelani C Mahungu, Jeannine M Heckmann, et al.
Frontiers in Neurology|September 15, 2023
The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegiaAmokelani C Mahungu, Elizabeth Steyn, Niki Floudiotis, et al.
Neurology. Genetics|January 20, 2022
Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral SclerosisMelissa Nel, Amokelani C Mahungu, Nomakhosazana Monnakgotla, et al.
Muscle & Nerve|June 5, 2025
MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia GravisKatherine A Buzzard, Anneke Van der Walt, Helmut Butzkueven, et al.
European Neurology|October 28, 2019
A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis ExacerbationsGuntis Karelis, Rodica Balasa, Jan L De Bleecker, et al.
Breast Cancer Research and Treatment|September 3, 1999
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study GroupO Kloke, U Klaassen, C Oberhoff, et al.
BMC Psychiatry|November 29, 2019
Save the children by treating their mothers (PriVileG-M-study) - study protocol: a sequentially randomized controlled trial of individualized psychotherapy and telemedicine to reduce mental stress in pregnant women and young mothers and to improve Child's healthM Bischoff, V Howland, J Klinger-König, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and AnalysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
Ebiomedicine|September 13, 2024
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
The Lancet. Neurology|February 21, 2026
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGADDalia L Rotstein, Raed Alroughani, Georgina Arrambide, et al.
Pageof 27